Amgen Valuation

AMGN Stock  USD 284.32  1.98  0.69%   
At this time, the firm appears to be overvalued. Amgen Inc shows a prevailing Real Value of $274.84 per share. The current price of the firm is $284.32. Our model approximates the value of Amgen Inc from analyzing the firm fundamentals such as profit margin of 0.24 %, and Return On Equity of 1.36 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Price Book
24.2307
Enterprise Value
204.7 B
Enterprise Value Ebitda
13.8284
Price Sales
5.3567
Forward PE
14.5138
Overvalued
Today
284.32
Please note that Amgen's price fluctuation is very steady at this time. Calculation of the real value of Amgen Inc is based on 3 months time horizon. Increasing Amgen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Amgen Inc is useful when determining the fair value of the Amgen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Amgen. Since Amgen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amgen Stock. However, Amgen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  284.32 Real  274.84 Target  258.8 Hype  286.32 Naive  286.87
The real value of Amgen Stock, also known as its intrinsic value, is the underlying worth of Amgen Inc Company, which is reflected in its stock price. It is based on Amgen's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Amgen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amgen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
273.38
Downside
274.84
Real Value
314.93
Upside
Estimating the potential upside or downside of Amgen Inc helps investors to forecast how Amgen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amgen more accurately as focusing exclusively on Amgen's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
3.633.995.16
Details
Hype
Prediction
LowEstimatedHigh
284.86286.32287.78
Details
Potential
Annual Dividend
LowForecastedHigh
5.375.535.69
Details
26 Analysts
Consensus
LowTarget PriceHigh
235.51258.80287.27
Details

Amgen Investments

(2.46 Billion)

Amgen Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Amgen's current stock value. Our valuation model uses many indicators to compare Amgen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amgen competition to find correlations between indicators driving Amgen's intrinsic value. More Info.
Amgen Inc is number one stock in net asset category among related companies. It is number one stock in five year return category among related companies . The ratio of Net Asset to Five Year Return for Amgen Inc is about  34,451,773,050 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amgen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amgen's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amgen's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Amgen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Amgen and how it compares across the competition.

About Amgen Valuation

The stock valuation mechanism determines the current worth of Amgen Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Amgen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Amgen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Amgen's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Amgen's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amgen. We calculate exposure to Amgen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amgen's related companies.
Last ReportedProjected for 2024
Gross Profit19.7 B20.7 B
Pretax Profit Margin 0.28  0.25 
Operating Profit Margin 0.28  0.26 
Net Profit Margin 0.24  0.18 
Gross Profit Margin 0.70  0.65 

8 Steps to conduct Amgen's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amgen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amgen's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Amgen's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Amgen's revenue streams: Identify Amgen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Amgen's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Amgen's growth potential: Evaluate Amgen's management, business model, and growth potential.
  • Determine Amgen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amgen's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Amgen's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Amgen's value is low or high relative to the company's performance and growth projections. Determining the market value of Amgen can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Amgen represents a small ownership stake in the entity. As a stockholder of Amgen, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Amgen Dividends Analysis For Valuation

As of the 28th of March 2024, Dividend Paid And Capex Coverage Ratio is likely to grow to 2.58, though Dividends Paid is likely to grow to (4.3 B). . As of the 28th of March 2024, Price Earnings To Growth Ratio is likely to grow to 7.72, though Retained Earnings are likely to grow to (25.2 B).
Last ReportedProjected for 2024
Dividends Paid-4.6 B-4.3 B
Dividend Yield 0.03  0.02 
Dividend Payout Ratio 0.68  0.42 
Dividend Paid And Capex Coverage Ratio 2.46  2.58 
There are various types of dividends Amgen can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Amgen shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Amgen Inc directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Amgen pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Amgen by the value of the dividends paid out.

Amgen Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Amgen does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding538 M
Quarterly Earnings Growth Y O Y-0.524
Forward Price Earnings14.5138

Amgen Current Valuation Indicators

Valuation refers to the process of determining the present value of Amgen Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Amgen we look at many different elements of the entity such as Amgen's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Amgen's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Amgen's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Amgen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Amgen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Amgen's worth.
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.48
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.